IP Library Granted Patent US 8,170,674
Granted Patent B2
US 8,170,674 · App. 12/039,165 · Granted May 1, 2012

Method of using spinal cord stimulation to treat gastrointestinal and/or eating disorders or conditions

Assignee: Advanced Neuromodulation Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,170,674
App. No.
12/039,165
Granted
May 1, 2012
Kind
B2
Abstract

The present invention involves a method and a system for using electrical stimulation to treat gastrointestinal and/or eating disorders. More particularly, the method comprises surgically implanting an electrical stimulation lead that is in communication with predetermined thoracic vertebral segments to cause spinal nervous tissue stimulation, thus treating a wide variety of gastrointestinal disorders.

Claims (10)

1. A method of treating irritable bowel syndrome using an electrical spinal cord stimulation system, comprising:

implanting an electrical lead within the thoracic T5, T5/T6 or T6 epidural space of the spinal cord of a patient;

selecting a plurality of operating parameters for the electrical spinal cord stimulation system that are effective for treating irritable bowel syndrome;

programming the electrical spinal cord system according to the plurality of operating parameters; and

treating the patient's irritable bowel syndrome by increasing gastric motility by activating the electrical spinal cord stimulation system to deliver electrical pulses to spinal nervous tissue within the thoracic T5, T5/T6 or T6 epidural space of the spinal cord of the patient wherein gastric function is normalized.

2. The method of claim 1 wherein the electrical spinal cord stimulation system delivers electrical pulses on a substantially continuous basis.

3. The method of claim 1 wherein the plurality of operating parameters include a pulse amplitude parameter, a pulse width parameter, and a pulse frequency parameter.

4. The method of claim 3 wherein the pulse frequency parameter is within the range of 10-350 Hz.

5. The method of claim 1 wherein the lead comprises a plurality of electrodes and the plurality of operating parameters include an electrode configuration.

6. The method of claim 1 wherein the patient has decreased nausea.

Continuity (4)
Continuation 11234960 · Sep 26, 2005
Provisional Application 60613495 · Sep 27, 2004
Provisional Application 60614312 · Sep 29, 2004
Related Publication 20080154329A1 · Jun 26, 2008